Skip to main content
. 2019 Aug 22;11(9):427. doi: 10.3390/pharmaceutics11090427

Scheme 1.

Scheme 1

Schematic presentation of the possible inclusion geometry of the Mel and gemini surfactant; (a) 1:1 βCD-Mel, (b) 18:1βCDg-Mel at 1:1 molar ratio, and (c) 18:1βCD-Mel at 3:1 molar ratio. Note that other possible geometries are possible and also the structures are not drawn to scale.